Active Biotech AB (0GQU) AI Stock Analysis

Active Biotech AB

(LSE:0GQU)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low LeverageVery low leverage limits the company’s debt burden and reduces exposure to interest or refinancing pressure. This provides more financial flexibility than a highly indebted biotech and supports continued development activity, although it does not eliminate the need for funding.

Negative Factors

No RevenueZero reported revenue leaves the business dependent on advancing and monetizing its therapeutics pipeline rather than funding operations through product sales. Without an established revenue base, financial performance remains highly dependent on future partnering or successful commercialization.

Active Biotech AB (0GQU) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: SEK 105.31M
Dividend Yield: ―
Average Volume (3M): 1,382
Price to Earnings (P/E): -10.1
Beta (1Y): 1.73
Revenue Growth: ―
EPS Growth: 54.60%
Country: UK
Employees: 5
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Active Biotech AB Business Overview & Revenue Model

Company Description

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which...

Active Biotech AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GB:0GQU against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CANTA	70Outperform	SEK 451.68M	2.35	63.09%	―	―	―
SE:HNSA	55Neutral	SEK 4.00B	-5.00	―	―	-3.57%	8.84%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:ONCO	47Neutral	SEK 721.66M	-2.14	―	―	87.23%	35.27%
SE:SYNACT	44Neutral	SEK 911.79M	-8.23	-58.12%	―	―	1.42%
SE:BINV	43Neutral	SEK 357.32M	-0.73	-128.54%	―	-83.67%	-50.29%

* Healthcare Sector Average

Performance Comparison

GB:0GQU and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0GQU	Active Biotech AB	3.19	-3.20	-50.04%
SE:HNSA	Hansa Biopharma	39.34	8.34	26.90%
SE:BINV	BioInvent International AB	5.43	-28.47	-83.98%
SE:ONCO	Oncopeptides AB	1.67	-3.75	-69.16%
SE:SYNACT	SynAct Pharma AB	16.22	-7.18	-30.68%
SE:CANTA	Cantargia AB	1.60	-1.97	-55.13%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Active Biotech AB AI Stock Analysis